Trendlines Group

Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.

Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.

AquiNovo is a company focused on developing innovative feed additives aimed at enhancing fish growth in the aquaculture industry. As the demand for fish protein rises and marine resources become increasingly depleted, AquiNovo addresses the need for sustainable solutions that optimize fish yields while utilizing existing resources and infrastructures. The company’s platform specializes in the creation of non-genetically modified and non-hormonal peptides that significantly improve gut performance and overall health in fish. This advancement not only boosts production yields for farmers but also offers potential treatments for gastrointestinal conditions in both production and companion animals, thereby contributing to the sustainability and efficiency of aquaculture practices.

BioFishency develops integrated water treatment solutions for land‑based aquaculture. Its plug‑and‑play system operates across extensive ponds, constructed ponds, and recirculating systems, allowing farms to double or triple production while retaining existing infrastructure. The technology addresses limited water availability and toxic ammonia buildup, improving water quality to enhance fish survival, growth, and reproduction. A cloud‑controlled, temperature‑agnostic platform delivers immediate operation, reduces water and energy use, eliminates off‑flavors, and lowers the carbon footprint, thereby boosting yields and operational efficiency.